Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact

Table of Contents

June 30, 2015 ;  100 (7)

Editorials

  • You have access
    The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A
    Valder R. Arruda
    Haematologica July 2015 100: 849-850; doi:10.3324/haematol.2015.129858
    • Disclosure
  • You have access
    Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia
    Ross M. W. Thorne, Thomas A. Milne
    Haematologica July 2015 100: 850-853; doi:10.3324/haematol.2015.129932
    • Disclosures and Contributions
  • You have access
    Rituximab maintenance therapy in diffuse large B-cell lymphoma: is XY the most important variable?
    Matthew A Lunning, James O Armitage
    Haematologica July 2015 100: 853-855; doi:10.3324/haematol.2015.129924
    • Disclosures and Contributions
  • You have access
    Personalized medicine in adult acute lymphoblastic leukemia
    Dieter Hoelzer
    Haematologica July 2015 100: 855-858; doi:10.3324/haematol.2015.127837
    • Disclosure

Review Article

  • You have access
    Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT
    Salyka Sengsayadeth, Bipin N. Savani, Didier Blaise, Florent Malard, Arnon Nagler, Mohamad Mohty
    Haematologica July 2015 100: 859-869; doi:10.3324/haematol.2015.123331
    • Disclosures and Contributions

Articles

Red Cell Biology & Its Disorders

  • You have access
    Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease
    Brian T. Kalish, Alessandro Matte, Immacolata Andolfo, Achille Iolascon, Olga Weinberg, Alessandra Ghigo, James Cimino, Angela Siciliano, Emilio Hirsch, Enrica Federti, Mark Puder, Carlo Brugnara, Lucia De Franceschi
    Haematologica July 2015 100: 870-880; doi:10.3324/haematol.2015.124586
    • Kalish et al. Supplementary Appendix
    • Disclosures and Contributions

Coagulation & Its Disorders

  • You have access
    Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A
    Diego Zanolini, Simone Merlin, Maria Feola, Gabriella Ranaldo, Angela Amoruso, Gianluca Gaidano, Mauro Zaffaroni, Alessandro Ferrero, Sandra Brunelleschi, Guido Valente, Sanjeev Gupta, Maria Prat, Antonia Follenzi
    Haematologica July 2015 100: 881-892; doi:10.3324/haematol.2014.123117
    • Zanolini et al. Graphical Abstract
    • Zanolini et al. Supplementary Appendix
    • Disclosures and Contributions

Myeloproliferative Disorders

  • You have access
    Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
    Carla Al Assaf, Florence Van Obbergh, Johan Billiet, Els Lierman, Timothy Devos, Carlos Graux, Anne-Sophie Hervent, Jan Emmerechts, Thomas Tousseyn, Pascale De Paepe, Petros Papadopoulos, Lucienne Michaux, Peter Vandenberghe
    Haematologica July 2015 100: 893-897; doi:10.3324/haematol.2014.118299
    • Al Assaf et al. Supplementary Appendix
    • Disclosures and Contributions
    • Disclosures and Contributions

Chronic Myeloid Leukemia

  • You have access
    A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy
    Gautam Borthakur, Herve Dombret, Philippe Schafhausen, Tim Henrik Brummendorf, Nicolas Boissel, Elias Jabbour, Mariangela Mariani, Laura Capolongo, Patrizia Carpinelli, Cristina Davite, Hagop Kantarjian, Jorge E. Cortes
    Haematologica July 2015 100: 898-904; doi:10.3324/haematol.2014.115279
    • Borthakur et al. Supplementary Appendix
    • Disclosures and Contributions

Acute Myeloid Leukemia

  • You have access
    Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia
    Maria-Paz Garcia-Cuellar, Julia Steger, Elisa Füller, Katrin Hetzner, Robert K. Slany
    Haematologica July 2015 100: 905-913; doi:10.3324/haematol.2015.124032
    • Garcia-Cuellar et al. Graphical Abstract
    • Garcia-Cuellar et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
    Erwin M. Lee, Dean Yee, Samantha J. Busfield, Julie F. McManus, Nik Cummings, Gino Vairo, Andrew Wei, Hayley S. Ramshaw, Jason A. Powell, Angel F. Lopez, Ian D. Lewis, Martin N. McCall, Richard B. Lock
    Haematologica July 2015 100: 914-926; doi:10.3324/haematol.2014.113092
    • Lee et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
    Marina Konopleva, Peter F. Thall, Cecilia Arana Yi, Gautam Borthakur, Andrew Coveler, Carlos Bueso-Ramos, Juliana Benito, Sergej Konoplev, Yongchuan Gu, Farhad Ravandi, Elias Jabbour, Stefan Faderl, Deborah Thomas, Jorge Cortes, Tapan Kadia, Steven Kornblau, Naval Daver, Naveen Pemmaraju, Hoang Q. Nguyen, Jennie Feliu, Hongbo Lu, Caimiao Wei, William R. Wilson, Teresa J. Melink, John C. Gutheil, Michael Andreeff, Elihu H. Estey, Hagop Kantarjian
    Haematologica July 2015 100: 927-934; doi:10.3324/haematol.2014.118455
    • Disclosures and Contributions
    • Konopleva et al. Supplementary Appendix

Acute Lymphoblastic Leukemia

  • You have access
    Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
    Leonid Karawajew, Michael Dworzak, Richard Ratei, Peter Rhein, Giuseppe Gaipa, Barbara Buldini, Giuseppe Basso, Ondrej Hrusak, Wolf-Dieter Ludwig, Günter Henze, Karl Seeger, Arend von Stackelberg, Ester Mejstrikova, Cornelia Eckert
    Haematologica July 2015 100: 935-944; doi:10.3324/haematol.2014.116707
    • Karawajew et al. Supplementary Appendix
    • Disclosures and Contributions

Chronic Lymphocytic Leukemia

  • You have access
    Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B
    Manoj K. Kashyap, Deepak Kumar, Reymundo Villa, James J. La Clair, Chris Benner, Roman Sasik, Harrison Jones, Emanuela M. Ghia, Laura Z. Rassenti, Thomas J. Kipps, Michael D. Burkart, Januario E. Castro
    Haematologica July 2015 100: 945-954; doi:10.3324/haematol.2014.122069
    • Kashyap et al. Graphical Abstract
    • Kashyap et al. Supplementary Appendix
    • Disclosures and Contributions

Non-Hodgkin Lymphoma

  • You have access
    Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
    Ulrich Jaeger, Marek Trneny, Helen Melzer, Michael Praxmarer, Weerasak Nawarawong, Dina Ben Yehuda, David Goldstein, Bilijana Mihaljevic, Osman Ilhan, Veronika Ballova, Michael Hedenus, Liang-Tsai Hsiao, Wing-Yan Au, Sonja Burgstaller, Gerhard Weidinger, Felix Keil, Christian Dittrich, Cathrin Skrabs, Anton Klingler, Andreas Chott, Michael A. Fridrik, Richard Greil
    Haematologica July 2015 100: 955-963; doi:10.3324/haematol.2015.125344
    • Jaeger et al. Graphical Abstract
    • Disclosures and Contributions

Plasma Cell Disorders

  • You have access
    Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial
    Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor W. Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Jens Hillengass, Marc S. Raab, Baerbel Schurich, Markus Munder, Ingo G.H. Schmidt-Wolf, Christian Gerecke, Hans-Walter Lindemann, Matthias Zeis, Katja Weisel, Jan Duerig, Hartmut Goldschmidt
    Haematologica July 2015 100: 964-969; doi:10.3324/haematol.2015.124347
    • Merz et al. Supplementary Appendix
    • Disclosures and Contributions

Stem Cell Transplantation

  • You have access
    Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
    Joseph Pidala, Jongphil Kim, Melissa Alsina, Ernesto Ayala, Brian C. Betts, Hugo F. Fernandez, Teresa Field, Heather Jim, Mohamed A. Kharfan-Dabaja, Frederick L. Locke, Asmita Mishra, Taiga Nishihori, Leonel Ochoa-Bayona, Lia Perez, Marcie Riches, Claudio Anasetti
    Haematologica July 2015 100: 970-977; doi:10.3324/haematol.2015.123588
    • Disclosures and Contributions

Immunodeficiencies

  • You have access
    The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis
    Sebastian FN Bode, Sandra Ammann, Waleed Al-Herz, Mihaela Bataneant, Christopher C Dvorak, Stephan Gehring, Andrew Gennery, Kimberly C Gilmour, Luis I Gonzalez-Granado, Ute Groß-Wieltsch, Marianne Ifversen, Jenny Lingman-Framme, Susanne Matthes-Martin, Rolf Mesters, Isabelle Meyts, Joris M van Montfrans, Jana Pachlopnik Schmid, Sung-Yun Pai, Pere Soler-Palacin, Uta Schuermann, Volker Schuster, Markus G. Seidel, Carsten Speckmann, Polina Stepensky, Karl-Walter Sykora, Bianca Tesi, Thomas Vraetz, Catherine Waruiru, Yenan T. Bryceson, Despina Moshous, Kai Lehmberg, Michael B Jordan, Stephan Ehl
    Haematologica July 2015 100: 978-988; doi:10.3324/haematol.2014.121608
    • Disclosures and Contributions

Online Only Articles

  • You have access
    Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
    Harinder Gill, Cheuk-Him Man, Alvin H.W. Ip, William W.L. Choi, Howard C.H. Chow, Yok-Lam Kwong, Anskar Y.H. Leung
    Haematologica July 2015 100: e250-e253; doi:10.3324/haematol.2014.123034
    • Gill et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia
    Daisuke Araki, Megan Othus, Roland B. Walter, Vicky Sandhu, Brenda M. Sandmaier, Pamela S. Becker, Frederick R. Appelbaum, Elihu H. Estey
    Haematologica July 2015 100: e254-e256; doi:10.3324/haematol.2014.118570
    • Araki et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis
    Sara Trabanelli, Antonio Curti, Mariangela Lecciso, Bérengère Salomé, Carsten Riether, Adrian Ochsenbein, Pedro Romero, Camilla Jandus
    Haematologica July 2015 100: e257-e260; doi:10.3324/haematol.2014.119602
    • Disclosures and Contributions
  • You have access
    Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates
    Judith M. Boer, Jasper E. Koenders, Bronno van der Holt, Carla Exalto, Mathijs A. Sanders, Jan J. Cornelissen, Peter J.M. Valk, Monique L. den Boer, Anita W. Rijneveld
    Haematologica July 2015 100: e261-e264; doi:10.3324/haematol.2014.117424
    • Boer et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia
    Adam Linley, Beatriz Valle-Argos, Andrew J. Steele, Freda K. Stevenson, Francesco Forconi, Graham Packham
    Haematologica July 2015 100: e265-e268; doi:10.3324/haematol.2014.120824
    • Linley et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma
    Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, Laure Lebras, Stephanie Harel, Sandy Amorin, Claire Reynes, Gilles Salles, Fabien Subtil, Pauline Brice
    Haematologica July 2015 100: e269-e271; doi:10.3324/haematol.2015.124784
    • Disclosures and Contributions
  • You have access
    Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma
    Yasuhiro Oki, Anas Younes, Javier Knickerbocker, Felipe Samaniego, Loretta Nastoupil, Fredrick Hagemeister, Jorge Romaguera, Nathan Fowler, Larry Kwak, Jason Westin
    Haematologica July 2015 100: e272-e274; doi:10.3324/haematol.2015.126557
    • Disclosures and Contributions
  • You have access
    Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern
    Julio Finalet Ferreiro, Julie Morscio, Daan Dierickx, Lukas Marcelis, Gregor Verhoef, Peter Vandenberghe, Thomas Tousseyn, Iwona Wlodarska
    Haematologica July 2015 100: e275-e279; doi:10.3324/haematol.2015.124305
    • Finalet Ferreiro et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
    Elodie Bohers, Pierre Julien Viailly, Sydney Dubois, Philippe Bertrand, Catherine Maingonnat, Sylvain Mareschal, Philippe Ruminy, Jean-Michel Picquenot, Christian Bastard, Fabienne Desmots, Thierry Fest, Karen Leroy, Hervé Tilly, Fabrice Jardin
    Haematologica July 2015 100: e280-e284; doi:10.3324/haematol.2015.123612
    • Bohers et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
    Michael Hahn, Paul Schnitzler, Brunhilde Schweiger, Christina Kunz, Anthony D. Ho, Hartmut Goldschmidt, Michael Schmitt
    Haematologica July 2015 100: e285-e288; doi:10.3324/haematol.2014.116772
    • Disclosures and Contributions
  • You have access
    Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma
    Enrique M. Ocio, Julio Dávila, Juan-Carlos Caballero, Sara Alonso, Verónica González de la Calle, Ramón García-Sanz, Lucien Gazi, Socrates Opio, Mónica Jiménez, Jesús F. San-Miguel, María-Victoria Mateos
    Haematologica July 2015 100: e289-e291; doi:10.3324/haematol.2015.124164
    • Disclosures and Contributions
Back to top
PreviousNext

In this issue

Haematologica: 100 (7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Jump to

  • Editorials
  • Review Article
  • Articles
  • Red Cell Biology & Its Disorders
  • Coagulation & Its Disorders
  • Myeloproliferative Disorders
  • Chronic Myeloid Leukemia
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Plasma Cell Disorders
  • Stem Cell Transplantation
  • Immunodeficiencies
  • Online Only Articles

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

 
Loading
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online